Collaborative Research: Role of Organic Matter Source on the Photochemical Fate of Pharmaceutical Compounds
Collaborative Research: Role of Organic Matter Source on the Photochemical Fate of Pharmaceutical Compounds
批准号:
1133600
负责人:
Allison MacKay
金额:
$29.97万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-01 至 2015-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PIs: Allison MacKay / Yu-Ping Chin / Charles SharplessProposal Numbers: 1133600 / 1133094 / 1132207Evaluating the impacts of human pharmaceutical compounds in the environment is a daunting task, given the wide variety of chemicals administered for medical conditions and the various wastewater management schemes that facilitate their release to aquatic systems. Prior studies suggest photodegradation reactions to be important attenuation processes for pharmaceutical compounds in the environment. The susceptibility of pharmaceuticals to photochemical reactions will be impacted by the co-release of these compounds with effluent organic matter (EfOM). EfOM is expected to have differing photoreactivity, relative to well-studied natural organic matter (NOM) sources, presumably because of its anticipated lower aromatic content and lower color, compared to NOM. The PIs hypothesize that pharmaceutical compound photodegradation will be altered with increasing proportion of wastewater effluent in natural channel flow because of the increased presence of EfOM, relative to NOM. The ultimate goal of the proposed research is to identify key environmental system characteristics that are associated with enhanced environmental photodegradation rates of pharmaceutical compounds. They propose three major research activities to evaluate their hypothesis. (1): Field measurements of environmental degradation rates and pathways will be obtained for representative wastewater discharge scenarios ? forested New England watershed (Pomperaug River, CT), agricultural Midwestern watershed (East Fork of the Little Miami River, OH), and an urban stream with combined sewer outfalls (Park River, CT). Flow-adjusted samples will be obtained downstream of the effluent discharge to measure pseudo-first order environmental degradation rates with differing seasonal EfOM-to-NOM ratios. Photolysis losses will be differentiated from other losses by comparing daytime and nighttime observations. Supporting lab degradation studies will resolve contributions of organic matter (OM) type to photochemical pathways. (2): OM will be isolated from the field sites, including from effluent streams directly. Isolation methods of XAD-8 resin and tangential flow ultrafiltration will be used for consistency with geochemistry methods. Isolates will be characterized for their biochemical constituents (thermochemolysis), and for optical and structural properties (UV-Vis, fluorescence, solid-state 13C NMR). (3): Quantum yields of singlet oxygen, hydrogen peroxide and excited triplet-state OM will be obtained for OM isolates and correlated to OM characteristics (Task 2). Together, the results of Tasks 2 and 3 will yield critical insights for interpreting differences in photodegradation rate constants (Task 1) among the sites and within seasons, as effluent contributions change at each site. This study will be the first to examine the fate of pharmaceutical compounds in New England and Midwestern rivers, expanding on prior fate studies from arid systems. They will establish an important body of knowledge about environmental system drivers of pharmaceutical compound fates that will contribute to robust science-based decisions about regulation, remediation, and/or ?green? design for pharmaceutical compounds. They will work closely with the Pomperaug River Watershed Coalition and the East Fork Watershed Cooperative to engage citizens in cutting-edge science through semi-annual project progress presentations, to involve water managers and community members in water quality sampling, and to organize a cross-disciplinary Roundtable to bring together environmental scientists and engineers, regulators, with ecologists and pharmacologists to discuss environmental management of pharmaceutical compounds in the environment. The PIs will mentor graduate and undergraduate researchers through the process of scientific discovery ? experimental design, manuscript preparation and national professional society presentations. The PIs will continue their record of engaging student researchers from groups underrepresented in the sciences and engineering. Students will have a unique opportunity to work with a guiding PI team with expertise in engineering (PI MacKay), geochemistry (PI Chin), photochemistry (PI Sharpless) and systems ecology (Collaborator Nietch), providing broad context for their own projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
REU Site: Undergraduate Research Experiences on Resilient and Sustainable of Infrastructure System in Smart Cities (RSISSC)
-
批准号:2244304
-
项目类别:Standard Grant
-
资助金额:$43.6万
-
财政年份:2023
-
负责人:Allison MacKay
-
依托单位:
2016 Gordon Research Conference on Environmental Sciences: Water: Opportunities for Aquatic Sciences to Impact a Changing World
-
批准号:1601288
-
项目类别:Standard Grant
-
资助金额:$4.0万
-
财政年份:2016
-
负责人:Allison MacKay
-
依托单位:
Collaborative Research: Novel Computational Tools to Predict Anionic Pesticide and Pharmaceutical Sorption to Soil Oxides
-
批准号:1604305
-
项目类别:Standard Grant
-
资助金额:$25.03万
-
财政年份:2016
-
负责人:Allison MacKay
-
依托单位:
Pharmaceutical Sorption to Model Soil Components
-
批准号:0225696
-
项目类别:Continuing Grant
-
资助金额:$0.0万
-
财政年份:2003
-
负责人:Allison MacKay
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Research on Quantum Field Theory without a Lagrangian Description
-
批准号:24ZR1403900
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:SATOSHI NAWATA
-
依托单位:
Cell Research
-
批准号:31224802
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2012
-
负责人:程磊
-
依托单位:
Cell Research
-
批准号:31024804
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2010
-
负责人:程磊
-
依托单位:
Cell Research (细胞研究)
-
批准号:30824808
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2008
-
负责人:张爱兰
-
依托单位:
Research on the Rapid Growth Mechanism of KDP Crystal
-
批准号:10774081
-
项目类别:面上项目
-
资助金额:45.0万元
-
批准年份:2007
-
负责人:滕冰
-
依托单位: